Livagen (20mg) Dosage Protocol
Livagen is a tetrapeptide (Lys-Glu-Asp-Ala) from the Khavinson bioregulator series designed to target liver tissue. Research suggests it may support hepatocyte function and liver regeneration processes.
Add 2.0 mL bacteriostatic water → 10 mg/mL
10-20 mg daily for 10-20 day cycles
At 10 mg/mL: 10 units = 1 mg, 100 units = 10 mg
Lyophilized: -20°C; Reconstituted: 2-8°C for up to 4 weeks
| Week | Daily Dose | Units (per injection) |
|---|---|---|
| Days 1-10 | 10 mg daily | 100 units (1.0 mL) |
| Days 11-20 | 10-20 mg daily | 100-200 units |
| Cycle off | 1-3 months | Before repeating |
- 1Draw 2.0 mL bacteriostatic water with a sterile syringe
- 2Inject slowly into the vial
- 3Gently swirl until fully dissolved
- 4Label with date and concentration, refrigerate immediately
Livagen is designed to target hepatocytes through peptide bioregulation. Research from the Khavinson series suggests it may support liver cell function, promote regeneration, and modulate gene expression related to hepatic health.
- Targets liver tissue specifically
- Research suggests hepatoprotective effects
- May support liver regeneration
- Part of comprehensive bioregulator protocols
- Khavinson VK, et al. Peptide bioregulators. Bull Exp Biol Med. 2011
- Khavinson VK. Peptide regulation of gene expression. Adv Gerontol. 2005
- Livagen hepatic tissue research
Lyophilized
Store at -20°C, protected from light
Reconstituted
Refrigerate at 2-8°C, use within 4 weeks
Part of Khavinson organ-specific bioregulator series
- •Research compound from Khavinson series
- •Not a substitute for liver medications
- •Use in short cycles with breaks
- •Often combined with other bioregulators
Disclaimer: This content is intended for research and educational purposes only. Not intended to diagnose, treat, cure, or prevent any disease. All compounds are for research use only. Dosing information is derived from published scientific literature and clinical studies.